CBD reversed mitochondrial damage from iron accumulation in a model of neurodegeneration

CBD rescued mitochondrial DNA damage, restored mitochondrial ferritin levels, and recovered enzyme activity in rats with iron-induced neurodegeneration, supporting its potential as a neuroprotective agent.

da Silva, Vanessa Kappel et al.·Brain research bulletin·2018·Preliminary EvidenceAnimal StudyAnimal Study
RTHC-01635Animal StudyPreliminary Evidence2018RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Iron accumulation in the brain is recognized as a contributing factor in neurodegenerative diseases. Researchers used a rat model of brain iron overload, previously shown to cause severe memory deficits and oxidative stress, to test whether CBD could protect mitochondria.

Iron loading caused multiple forms of mitochondrial damage: deletions in mitochondrial DNA, decreased epigenetic regulation of mitochondrial DNA, reduced mitochondrial ferritin levels, and impaired succinate dehydrogenase activity (a key enzyme in cellular energy production).

CBD treatment for 14 days in adulthood rescued several of these changes. It restored mitochondrial ferritin levels, recovered the epigenetic regulation of mitochondrial DNA, and normalized succinate dehydrogenase activity. These molecular-level rescues provide specific targets through which CBD may exert neuroprotective effects.

The findings support CBD as a potential disease-modifying agent rather than just a symptom manager in neurodegenerative diseases.

Key Numbers

CBD treatment: 14 days in adulthood. Iron-induced changes rescued by CBD: mitochondrial ferritin levels, epigenetic modulation of mtDNA, succinate dehydrogenase activity. Iron-induced changes not fully rescued: mtDNA deletions (not reported as rescued).

How They Did This

Rats received iron in the neonatal period to induce brain iron accumulation. In adulthood, they received CBD for 14 consecutive days. Mitochondrial DNA integrity, epigenetic modulation, mitochondrial ferritin levels, and succinate dehydrogenase activity were measured in brain tissue.

Why This Research Matters

Neurodegenerative diseases like Parkinson's and Alzheimer's involve iron accumulation and mitochondrial dysfunction. Identifying specific molecular targets through which CBD protects mitochondria provides a mechanistic basis for developing CBD-based neuroprotective treatments, moving beyond the general claim of "neuroprotection" to specific biological pathways.

The Bigger Picture

Mitochondrial dysfunction is a hallmark of multiple neurodegenerative diseases. Identifying compounds that can protect or restore mitochondrial function is a major goal of neuroscience research. CBD's ability to target mitochondrial pathways adds to its growing profile as a multi-target neuroprotective compound.

What This Study Doesn't Tell Us

This is an animal model of iron-induced neurodegeneration that may not fully replicate human neurodegenerative diseases. The iron loading was artificial, administered in the neonatal period. CBD dosing may not reflect clinically achievable brain concentrations in humans. Long-term effects and behavioral correlates were not assessed in this study.

Questions This Raises

  • ?Does CBD reach brain concentrations sufficient to produce these mitochondrial effects in humans?
  • ?Would chronic CBD administration prevent iron-related neurodegeneration if started before symptoms appear?
  • ?Could CBD be combined with iron chelators for enhanced neuroprotection?

Trust & Context

Key Stat:
CBD restored mitochondrial function damaged by iron-induced neurodegeneration
Evidence Grade:
This is a preclinical animal study providing preliminary evidence for specific molecular mechanisms of CBD neuroprotection.
Study Age:
Published in 2018. CBD neuroprotection research continues to identify molecular targets.
Original Title:
Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration: Reversal by cannabidiol.
Published In:
Brain research bulletin, 139, 1-8 (2018)
Database ID:
RTHC-01635

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

Can CBD protect the brain from neurodegeneration?

In this animal model, CBD rescued several forms of mitochondrial damage caused by iron accumulation, which is associated with neurodegenerative diseases like Parkinson's and Alzheimer's. However, this has not been confirmed in human clinical trials.

How does CBD protect mitochondria?

CBD restored mitochondrial ferritin levels (which help manage iron safely), recovered the epigenetic regulation of mitochondrial DNA, and normalized a key enzyme for energy production (succinate dehydrogenase). These specific molecular targets provide a clearer picture of how CBD may work as a neuroprotectant.

Read More on RethinkTHC

Cite This Study

RTHC-01635·https://rethinkthc.com/research/RTHC-01635

APA

da Silva, Vanessa Kappel; de Freitas, Betânia Souza; Dornelles, Victória Campos; Kist, Luiza Wilges; Bogo, Maurício Reis; Silva, Milena Carvalho; Streck, Emílio Luiz; Hallak, Jaime Eduardo; Zuardi, Antônio Waldo; Crippa, José Alexandre S; Schröder, Nadja. (2018). Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration: Reversal by cannabidiol.. Brain research bulletin, 139, 1-8. https://doi.org/10.1016/j.brainresbull.2018.01.014

MLA

da Silva, Vanessa Kappel, et al. "Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration: Reversal by cannabidiol.." Brain research bulletin, 2018. https://doi.org/10.1016/j.brainresbull.2018.01.014

RethinkTHC

RethinkTHC Research Database. "Novel insights into mitochondrial molecular targets of iron-..." RTHC-01635. Retrieved from https://rethinkthc.com/research/da-2018-novel-insights-into-mitochondrial

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.